Surgeons need to adapt to evolving treatments for unresectable colorectal liver metastases (uCRLM) that significantly impact outcomes. Advances in systemic therapy combined with liver-directed strategies have broadened curative options, using techniques like ablation and transarterial therapies. Patient selection now focuses on tumor biology and therapy response, moving away from strict anatomy-based criteria. Early referral to […]
Category: Intestine and Lower Gastrointestinal Tract
New robotic force feedback enhances safety in rectal surgery
Robotic rectal cancer surgery with da Vinci’s new force feedback technology shows promise for reducing tissue stress during procedures. Mean force during static retraction dropped significantly with higher feedback sensitivity (off: 3.07 n, low: 2.58 n, medium: 2.03 n; pā=ā0.039). Median maximum force in dynamic retraction also decreased with increased sensitivity (off: 36.19 n, low: […]
Bowel Prep’s Role in Elective Colectomy Outcomes
Combining mechanical bowel preparation with oral antibiotics significantly reduces complications after elective colectomy for colon cancer. Surgical site infection dropped from 8.7% without prep to 5.0% with combined prep. All bowel prep regimens lowered the risk of postoperative complications versus no prep, with combined prep showing the best relative risk reduction (infection: 0.60, leak: 0.66, […]
International Consensus on Presacral Tumor Management
This consensus sets new guidelines for diagnosing and managing presacral tumors, enhancing surgical practices and patient outcomes. High-resolution MRI with structured reporting is crucial for risk stratification. Image-guided biopsies are necessary for high-risk lesions needing histological confirmation. Tailor surgical approaches to tumor biology, with complete resection as the goal. Non-operative surveillance is advocated for low-risk, […]
Omitting Lateral Node Dissection in Rectal Cancer Safe
Lateral pelvic lymph node dissection in rectal cancer patients with responsive nodes after neoadjuvant therapy shows no survival benefit, impacting surgical strategies. No significant differences in 5-year local recurrence rates (3.1% vs. 5.3%), disease-free survival (77.1% vs. 71.4%), or overall survival (87.0% vs. 86.9%) with or without dissection. Dissection led to longer operative times (279.3 […]
Multimodal Prehabilitation Cuts Complications in Colorectal Surgery
A national study shows that multimodal prehabilitation significantly reduces complications in colorectal cancer surgery, improving outcomes for patients. Overall complication rates dropped from 37.8% to 30.1% in the prehabilitation group (odds ratio 0.71). Medical complications decreased from 24.6% to 15.4% (odds ratio 0.56). Length of hospital stay was reduced by 1 day, from 5 to […]
Survival Tied to Timely, Guideline-Concordant Care in Cancer
Optimal treatment timing significantly impacts survival in localized colon, lung, and pancreatic cancers. 68.7% of colon cancer, 70.6% of non-small cell lung cancer (NSCLC), and 22.6% of pancreatic cancer patients received optimal care. Patients receiving optimal care had much lower death risk: colon cancer HR 0.45, NSCLC HR 0.35, pancreatic cancer HR 0.46. Optimal care’s […]
Trends in Perioperative Chemotherapy for Colorectal Liver Metastases
Perioperative chemotherapy shows a survival edge for patients undergoing hepatectomy for colorectal liver metastases, but use is declining. Among 3,752 patients who had surgery, 54% received some form of perioperative chemotherapy. Survival improved significantly with both pre- and postoperative regimens (hazard ratio, 0.54). Complication risks and patient selection remain crucial; higher use is seen in […]
Postdischarge risks in nonoperative diverticulitis care
Nonoperative management of complicated diverticulitis significantly increases readmission risks. 33.9% of nonoperatively managed patients were readmitted due to recurrence, compared to just 4.8% of those who underwent surgery. Nonoperatively managed patients had 9-fold higher odds of readmission and were 3 times more likely to need surgery upon readmission. Surgeons should carefully consider the need for […]
Adjuvant Radiation Therapy Boosts Survival in Early Anal Cancer
Patients with T1-2 N0 anal squamous cell carcinoma benefit significantly from adjuvant radiation therapy after local excision. Five-year overall survival rates were 82.8% with radiation versus 74.9% without (p < .001). The benefit was especially marked in those with positive surgical margins (79.9% vs 67.2%; p = .003) and in women ā„65 years (85.8% vs […]